MERGER AGREEMENT between CILAG HOLDING AG and CRUCELL N.V.Merger Agreement • October 7th, 2010 • Johnson & Johnson • Pharmaceutical preparations
Expected date and time Event No later than on the third Business Day following the Closing Date Unconditional Date Promptly following the Unconditional Date Commencement of post-Acceptance Period / subsequent offering period No later than on the third Trading Day following the Unconditional Date, unforeseen circumstances excepted Settlement Date 29 days after Closing Date (after giving effect to any extension of the Acceptance Period) Post Offer EGM
IRREVOCABLE UNDERTAKINGPrivate and Confidential • October 7th, 2010 • Johnson & Johnson • Pharmaceutical preparations
Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of €24.75 per Ordinary Share of CrucellJohnson & Johnson • October 7th, 2010 • Pharmaceutical preparations
New Brunswick, N.J., and Leiden, the Netherlands, (October 6, 2010) – Johnson & Johnson (NYSE: JNJ) and Crucell N.V. (NYSE Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced an agreement whereby Johnson & Johnson, through an affiliate, would acquire all outstanding equity of Crucell that it does not already own for approximately € 1.75 billion in a recommended cash tender offer (the Offer).
